After Years of Trial and Error, Biotech is Seeing More Successes Than Ever
Amicus Therapeutics Chairman John Crowley joins the show to discuss the state of the biotech industry and ensuring those who are in need have access to medications
This Week in Business · Wharton Podcast Network
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
John Crowley, Chairman & Former CEO of Amicus Therapeutics, joins the show to discuss the strides the biotech industry has made in therapies for rare genetic diseases and the industry landscape going forward.
This interview originally aired as part of Wharton Business Daily's Business of Healthcare special.
Hosted on Acast. See acast.com/privacy for more information.